View Future GrowthThis company has been acquiredThe company may no longer be operating, as it has been acquired. Find out why through their latest events.See Latest EventsOcean Bio-Chem 과거 순이익 실적과거 기준 점검 1/6핵심 정보27.80%순이익 성장률27.14%주당순이익(EPS) 성장률Household Products 산업 성장률1.51%매출 성장률12.73%자기자본이익률10.22%순이익률7.69%최근 순이익 업데이트30 Jun 2022최근 과거 실적 업데이트Reported Earnings • Aug 05Second quarter 2022 earnings released: US$0.03 loss per share (vs US$0.27 profit in 2Q 2021)Second quarter 2022 results: US$0.03 loss per share (down from US$0.27 profit in 2Q 2021). Revenue: US$15.2m (down 3.1% from 2Q 2021). Net loss: US$321.4k (down 112% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • May 16First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.20 in 1Q 2021)First quarter 2022 results: EPS: US$0.14 (down from US$0.20 in 1Q 2021). Revenue: US$12.7m (down 3.0% from 1Q 2021). Net income: US$1.30m (down 32% from 1Q 2021). Profit margin: 10% (down from 14% in 1Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.Reported Earnings • Apr 01Full year 2021 earnings released: EPS: US$0.89 (vs US$1.02 in FY 2020)Full year 2021 results: EPS: US$0.89 (down from US$1.02 in FY 2020). Revenue: US$64.3m (up 16% from FY 2020). Net income: US$8.40m (down 13% from FY 2020). Profit margin: 13% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.분석 기사 • Nov 22Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft EarningsA lackluster earnings announcement from Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) last week didn't sink the stock price. We...Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS US$0.34 (vs US$0.49 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: US$21.5m (up 12% from 3Q 2020). Net income: US$3.27m (down 30% from 3Q 2020). Profit margin: 15% (down from 24% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS US$0.27 (vs US$0.36 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: US$31.4m (up 100% from 2Q 2020). Net income: US$6.69m (up 94% from 2Q 2020). Profit margin: 21% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.모든 업데이트 보기Recent updatesReported Earnings • Aug 05Second quarter 2022 earnings released: US$0.03 loss per share (vs US$0.27 profit in 2Q 2021)Second quarter 2022 results: US$0.03 loss per share (down from US$0.27 profit in 2Q 2021). Revenue: US$15.2m (down 3.1% from 2Q 2021). Net loss: US$321.4k (down 112% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.분석 기사 • Jun 23Here's Why Ocean Bio-Chem (NASDAQ:OBCI) Can Manage Its Debt ResponsiblyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improved over the past weekAfter last week's 101% share price gain to US$12.86, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 20x in the Household Products industry in the US. Total returns to shareholders of 298% over the past three years.Reported Earnings • May 16First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.20 in 1Q 2021)First quarter 2022 results: EPS: US$0.14 (down from US$0.20 in 1Q 2021). Revenue: US$12.7m (down 3.0% from 1Q 2021). Net income: US$1.30m (down 32% from 1Q 2021). Profit margin: 10% (down from 14% in 1Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 7 highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Kim Krause was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.분석 기사 • Apr 07Capital Investments At Ocean Bio-Chem (NASDAQ:OBCI) Point To A Promising FutureIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...Reported Earnings • Apr 01Full year 2021 earnings released: EPS: US$0.89 (vs US$1.02 in FY 2020)Full year 2021 results: EPS: US$0.89 (down from US$1.02 in FY 2020). Revenue: US$64.3m (up 16% from FY 2020). Net income: US$8.40m (down 13% from FY 2020). Profit margin: 13% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.분석 기사 • Dec 16Ocean Bio-Chem (NASDAQ:OBCI) Might Become A Compounding MachineIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...분석 기사 • Nov 26Ocean Bio-Chem's (NASDAQ:OBCI) Dividend Will Be US$0.03Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) will pay a dividend of US$0.03 on the 21st of December. This means the annual...분석 기사 • Nov 22Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft EarningsA lackluster earnings announcement from Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) last week didn't sink the stock price. We...Valuation Update With 7 Day Price Move • Nov 22Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to US$9.50, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 24x in the Household Products industry in the US. Total returns to shareholders of 182% over the past three years.Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS US$0.34 (vs US$0.49 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: US$21.5m (up 12% from 3Q 2020). Net income: US$3.27m (down 30% from 3Q 2020). Profit margin: 15% (down from 24% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.분석 기사 • Nov 03These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt SafelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...분석 기사 • Sep 02Ocean Bio-Chem (NASDAQ:OBCI) Will Pay A Dividend Of US$0.03Ocean Bio-Chem, Inc.'s ( NASDAQ:OBCI ) investors are due to receive a payment of US$0.03 per share on 23rd of...Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS US$0.27 (vs US$0.36 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: US$31.4m (up 100% from 2Q 2020). Net income: US$6.69m (up 94% from 2Q 2020). Profit margin: 21% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.분석 기사 • Aug 17With EPS Growth And More, Ocean Bio-Chem (NASDAQ:OBCI) Is InterestingLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...Valuation Update With 7 Day Price Move • Aug 16Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to US$8.99, the stock trades at a trailing P/E ratio of 7.8x. Average trailing P/E is 21x in the Household Products industry in the US. Total returns to shareholders of 138% over the past three years.Seeking Alpha • Aug 05Ocean Bio-Chem And Its Real ValueOver a year and a half, OBCI shares have increased by 212.3%. OBCI had an impressive EBIT growth of 220% over the last year. Its operating margin is 22.90%, ranking better than 91% of the companies in Conglomerates industry. This article tells what investors could likely make in the future with OBCI and what the real value is versus the current share price.분석 기사 • Jul 27Is Ocean Bio-Chem (NASDAQ:OBCI) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$13.00, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 17x in the Household Products industry in the US. Total returns to shareholders of 261% over the past three years.Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$12.83, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 18x in the Household Products industry in the US. Total returns to shareholders of 269% over the past three years.분석 기사 • May 29Estimating The Intrinsic Value Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI)Does the May share price for Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) reflect what it's really worth? Today, we will...분석 기사 • May 17Investors Should Be Encouraged By Ocean Bio-Chem's (NASDAQ:OBCI) Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...Reported Earnings • May 16First quarter 2021 earnings released: EPS US$0.20 (vs US$0.066 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$13.1m (up 68% from 1Q 2020). Net income: US$1.90m (up 204% from 1Q 2020). Profit margin: 14% (up from 8.0% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year whereas the company’s share price has increased by 50% per year.Valuation Update With 7 Day Price Move • Apr 20Investor sentiment improved over the past weekAfter last week's 19% share price gain to US$14.17, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 20x in the Household Products industry in the US. Total returns to shareholders of 308% over the past three years.Reported Earnings • Apr 03Full year 2020 earnings released: EPS US$1.02 (vs US$0.37 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: US$55.6m (up 32% from FY 2019). Net income: US$9.62m (up 175% from FY 2019). Profit margin: 17% (up from 8.3% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 49% per year.분석 기사 • Mar 17Ocean Bio-Chem (NASDAQ:OBCI) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Valuation Update With 7 Day Price Move • Mar 13Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$12.50, the stock is trading at a trailing P/E ratio of 12.6x, up from the previous P/E ratio of 10.9x. This compares to an average P/E of 21x in the Household Products industry in the US. Total returns to shareholders over the past three years are 239%.분석 기사 • Mar 05Be Sure To Check Out Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Before It Goes Ex-DividendOcean Bio-Chem, Inc. ( NASDAQ:OBCI ) is about to trade ex-dividend in the next four days. If you purchase the stock on...분석 기사 • Feb 22Why Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Is A Dividend RockstarDividend paying stocks like Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) tend to be popular with investors, and for good reason...Valuation Update With 7 Day Price Move • Feb 18Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to US$10.32, the stock is trading at a trailing P/E ratio of 10.4x, down from the previous P/E ratio of 13x. This compares to an average P/E of 19x in the Household Products industry in the US. Total returns to shareholders over the past three years are 177%.Is New 90 Day High Low • Feb 18New 90-day low: US$10.32The company is down 20% from its price of US$12.86 on 19 November 2020. The American market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is down 7.0% over the same period.분석 기사 • Feb 09Why We Like The Returns At Ocean Bio-Chem (NASDAQ:OBCI)Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...분석 기사 • Jan 27Is Weakness In Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?Ocean Bio-Chem (NASDAQ:OBCI) has had a rough three months with its share price down 14%. However, stock prices are...분석 기사 • Jan 14Do Ocean Bio-Chem's (NASDAQ:OBCI) Earnings Warrant Your Attention?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...Is New 90 Day High Low • Jan 07New 90-day low: US$12.17The company is down 20% from its price of US$15.22 on 08 October 2020. The American market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is flat over the same period.분석 기사 • Jan 01This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)We'd be surprised if Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) shareholders haven't noticed that the Executive VP of Sales...Recent Insider Transactions • Dec 31Board Member recently sold US$120k worth of stockOn the 29th of December, Gregor Dornau sold around 9k shares on-market at roughly US$14.07 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$464k more than they bought in the last 12 months.분석 기사 • Dec 28Shareholders of Ocean Bio-Chem (NASDAQ:OBCI) Must Be Delighted With Their 610% Total ReturnLong term investing can be life changing when you buy and hold the truly great businesses. And highest quality...분석 기사 • Dec 15Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been SellingIt is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...분석 기사 • Dec 03Is Ocean Bio-Chem (NASDAQ:OBCI) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...분석 기사 • Nov 21A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO SalaryPeter Dornau has been the CEO of Ocean Bio-Chem, Inc. (NASDAQ:OBCI) since 1973, and this article will examine the...Valuation Update With 7 Day Price Move • Nov 21Market pulls back on stock over the past weekAfter last week's 18% share price decline to US$12.43, the stock is trading at a trailing P/E ratio of 12.5x, down from the previous P/E ratio of 15.3x. This compares to an average P/E of 24x in the Household Products industry in the US. Total returns to shareholders over the past three years are 209%.Reported Earnings • Nov 15Third quarter 2020 earnings released: EPS US$0.49The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$19.2m (up 53% from 3Q 2019). Net income: US$4.66m (up 314% from 3Q 2019). Profit margin: 24% (up from 9.0% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth.Valuation Update With 7 Day Price Move • Nov 10Market pulls back on stock over the past weekAfter last week's 26% share price decline to US$12.50, the stock is trading at a trailing P/E ratio of 20.1x, down from the previous P/E ratio of 27.1x. This compares to an average P/E of 23x in the Household Products industry in the US. Total returns to shareholders over the past three years are 212%.Valuation Update With 7 Day Price Move • Oct 21Market bids up stock over the past weekAfter last week's 17% share price gain to US$17.48, the stock is trading at a trailing P/E ratio of 28.2x, up from the previous P/E ratio of 24.1x. This compares to an average P/E of 26x in the Household Products industry in the US. Total returns to shareholders over the past three years are 280%.Recent Insider Transactions • Sep 18COO, VP recently sold US$72k worth of stockOn the 16th of September, William Dudman sold around 5k shares on-market at roughly US$15.50 per share. In the last 3 months, there was an even bigger sale from another insider worth US$90k. William has been a seller over the last 12 months, reducing personal holdings by US$154k.매출 및 비용 세부 내역Ocean Bio-Chem가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이NasdaqCM:OBCI 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비30 Jun 2263514031 Mar 2264814031 Dec 2164813030 Sep 2163913030 Jun 21611012031 Mar 21611112031 Dec 20561011030 Sep 2052911030 Jun 2046611031 Mar 2041311031 Dec 1942311030 Sep 1941311030 Jun 1942311031 Mar 1942311031 Dec 1842311030 Sep 1842311030 Jun 1840311031 Mar 1838310031 Dec 1738310030 Sep 1738310030 Jun 1739310031 Mar 1738310031 Dec 1636210030 Sep 1636210030 Jun 163509031 Mar 1635010031 Dec 153409030 Sep 1534190양질의 수익: OBCI의 비현금 수익 수준이 높습니다.이익 마진 증가: OBCI의 현재 순 이익률 (7.7%)은 지난해 (16.5%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: OBCI의 수익은 지난 5년 동안 연평균 27.8%로 크게 증가했습니다.성장 가속화: OBCI은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: OBCI은 지난 1년 동안 수익이 감소(-51.4%)하여 Household Products 업계 평균(10.1%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: OBCI의 자본 수익률(10.2%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YHousehold 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2022/08/09 18:59종가2022/08/08 00:00수익2022/06/30연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Ocean Bio-Chem, Inc.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Aug 05Second quarter 2022 earnings released: US$0.03 loss per share (vs US$0.27 profit in 2Q 2021)Second quarter 2022 results: US$0.03 loss per share (down from US$0.27 profit in 2Q 2021). Revenue: US$15.2m (down 3.1% from 2Q 2021). Net loss: US$321.4k (down 112% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • May 16First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.20 in 1Q 2021)First quarter 2022 results: EPS: US$0.14 (down from US$0.20 in 1Q 2021). Revenue: US$12.7m (down 3.0% from 1Q 2021). Net income: US$1.30m (down 32% from 1Q 2021). Profit margin: 10% (down from 14% in 1Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Apr 01Full year 2021 earnings released: EPS: US$0.89 (vs US$1.02 in FY 2020)Full year 2021 results: EPS: US$0.89 (down from US$1.02 in FY 2020). Revenue: US$64.3m (up 16% from FY 2020). Net income: US$8.40m (down 13% from FY 2020). Profit margin: 13% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
분석 기사 • Nov 22Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft EarningsA lackluster earnings announcement from Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) last week didn't sink the stock price. We...
Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS US$0.34 (vs US$0.49 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: US$21.5m (up 12% from 3Q 2020). Net income: US$3.27m (down 30% from 3Q 2020). Profit margin: 15% (down from 24% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS US$0.27 (vs US$0.36 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: US$31.4m (up 100% from 2Q 2020). Net income: US$6.69m (up 94% from 2Q 2020). Profit margin: 21% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 05Second quarter 2022 earnings released: US$0.03 loss per share (vs US$0.27 profit in 2Q 2021)Second quarter 2022 results: US$0.03 loss per share (down from US$0.27 profit in 2Q 2021). Revenue: US$15.2m (down 3.1% from 2Q 2021). Net loss: US$321.4k (down 112% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has increased by 54% per year, which means it is tracking significantly ahead of earnings growth.
분석 기사 • Jun 23Here's Why Ocean Bio-Chem (NASDAQ:OBCI) Can Manage Its Debt ResponsiblyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Valuation Update With 7 Day Price Move • Jun 22Investor sentiment improved over the past weekAfter last week's 101% share price gain to US$12.86, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 20x in the Household Products industry in the US. Total returns to shareholders of 298% over the past three years.
Reported Earnings • May 16First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.20 in 1Q 2021)First quarter 2022 results: EPS: US$0.14 (down from US$0.20 in 1Q 2021). Revenue: US$12.7m (down 3.0% from 1Q 2021). Net income: US$1.30m (down 32% from 1Q 2021). Profit margin: 10% (down from 14% in 1Q 2021). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 1 experienced director. 7 highly experienced directors. 3 independent directors (5 non-independent directors). Independent Director Kim Krause was the last independent director to join the board, commencing their role in 2016. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
분석 기사 • Apr 07Capital Investments At Ocean Bio-Chem (NASDAQ:OBCI) Point To A Promising FutureIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. One common...
Reported Earnings • Apr 01Full year 2021 earnings released: EPS: US$0.89 (vs US$1.02 in FY 2020)Full year 2021 results: EPS: US$0.89 (down from US$1.02 in FY 2020). Revenue: US$64.3m (up 16% from FY 2020). Net income: US$8.40m (down 13% from FY 2020). Profit margin: 13% (down from 17% in FY 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 46% per year but the company’s share price has only increased by 37% per year, which means it is significantly lagging earnings growth.
분석 기사 • Dec 16Ocean Bio-Chem (NASDAQ:OBCI) Might Become A Compounding MachineIf we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...
분석 기사 • Nov 26Ocean Bio-Chem's (NASDAQ:OBCI) Dividend Will Be US$0.03Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) will pay a dividend of US$0.03 on the 21st of December. This means the annual...
분석 기사 • Nov 22Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft EarningsA lackluster earnings announcement from Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) last week didn't sink the stock price. We...
Valuation Update With 7 Day Price Move • Nov 22Investor sentiment deteriorated over the past weekAfter last week's 17% share price decline to US$9.50, the stock trades at a trailing P/E ratio of 10.4x. Average trailing P/E is 24x in the Household Products industry in the US. Total returns to shareholders of 182% over the past three years.
Reported Earnings • Nov 17Third quarter 2021 earnings released: EPS US$0.34 (vs US$0.49 in 3Q 2020)The company reported a soft third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: US$21.5m (up 12% from 3Q 2020). Net income: US$3.27m (down 30% from 3Q 2020). Profit margin: 15% (down from 24% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 43% per year, which means it is significantly lagging earnings growth.
분석 기사 • Nov 03These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt SafelySome say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
분석 기사 • Sep 02Ocean Bio-Chem (NASDAQ:OBCI) Will Pay A Dividend Of US$0.03Ocean Bio-Chem, Inc.'s ( NASDAQ:OBCI ) investors are due to receive a payment of US$0.03 per share on 23rd of...
Reported Earnings • Aug 18Second quarter 2021 earnings released: EPS US$0.27 (vs US$0.36 in 2Q 2020)The company reported a solid second quarter result with improved earnings and revenues, although profit margins were flat. Second quarter 2021 results: Revenue: US$31.4m (up 100% from 2Q 2020). Net income: US$6.69m (up 94% from 2Q 2020). Profit margin: 21% (in line with 2Q 2020). Over the last 3 years on average, earnings per share has increased by 55% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth.
분석 기사 • Aug 17With EPS Growth And More, Ocean Bio-Chem (NASDAQ:OBCI) Is InterestingLike a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...
Valuation Update With 7 Day Price Move • Aug 16Investor sentiment deteriorated over the past weekAfter last week's 19% share price decline to US$8.99, the stock trades at a trailing P/E ratio of 7.8x. Average trailing P/E is 21x in the Household Products industry in the US. Total returns to shareholders of 138% over the past three years.
Seeking Alpha • Aug 05Ocean Bio-Chem And Its Real ValueOver a year and a half, OBCI shares have increased by 212.3%. OBCI had an impressive EBIT growth of 220% over the last year. Its operating margin is 22.90%, ranking better than 91% of the companies in Conglomerates industry. This article tells what investors could likely make in the future with OBCI and what the real value is versus the current share price.
분석 기사 • Jul 27Is Ocean Bio-Chem (NASDAQ:OBCI) A Risky Investment?Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Valuation Update With 7 Day Price Move • Jul 26Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$13.00, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 17x in the Household Products industry in the US. Total returns to shareholders of 261% over the past three years.
Valuation Update With 7 Day Price Move • Jun 25Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$12.83, the stock trades at a trailing P/E ratio of 11.2x. Average trailing P/E is 18x in the Household Products industry in the US. Total returns to shareholders of 269% over the past three years.
분석 기사 • May 29Estimating The Intrinsic Value Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI)Does the May share price for Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) reflect what it's really worth? Today, we will...
분석 기사 • May 17Investors Should Be Encouraged By Ocean Bio-Chem's (NASDAQ:OBCI) Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Reported Earnings • May 16First quarter 2021 earnings released: EPS US$0.20 (vs US$0.066 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: US$13.1m (up 68% from 1Q 2020). Net income: US$1.90m (up 204% from 1Q 2020). Profit margin: 14% (up from 8.0% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 53% per year whereas the company’s share price has increased by 50% per year.
Valuation Update With 7 Day Price Move • Apr 20Investor sentiment improved over the past weekAfter last week's 19% share price gain to US$14.17, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 20x in the Household Products industry in the US. Total returns to shareholders of 308% over the past three years.
Reported Earnings • Apr 03Full year 2020 earnings released: EPS US$1.02 (vs US$0.37 in FY 2019)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: US$55.6m (up 32% from FY 2019). Net income: US$9.62m (up 175% from FY 2019). Profit margin: 17% (up from 8.3% in FY 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 46% per year whereas the company’s share price has increased by 49% per year.
분석 기사 • Mar 17Ocean Bio-Chem (NASDAQ:OBCI) Seems To Use Debt Rather SparinglyLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Valuation Update With 7 Day Price Move • Mar 13Investor sentiment improved over the past weekAfter last week's 16% share price gain to US$12.50, the stock is trading at a trailing P/E ratio of 12.6x, up from the previous P/E ratio of 10.9x. This compares to an average P/E of 21x in the Household Products industry in the US. Total returns to shareholders over the past three years are 239%.
분석 기사 • Mar 05Be Sure To Check Out Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Before It Goes Ex-DividendOcean Bio-Chem, Inc. ( NASDAQ:OBCI ) is about to trade ex-dividend in the next four days. If you purchase the stock on...
분석 기사 • Feb 22Why Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Is A Dividend RockstarDividend paying stocks like Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) tend to be popular with investors, and for good reason...
Valuation Update With 7 Day Price Move • Feb 18Investor sentiment deteriorated over the past weekAfter last week's 20% share price decline to US$10.32, the stock is trading at a trailing P/E ratio of 10.4x, down from the previous P/E ratio of 13x. This compares to an average P/E of 19x in the Household Products industry in the US. Total returns to shareholders over the past three years are 177%.
Is New 90 Day High Low • Feb 18New 90-day low: US$10.32The company is down 20% from its price of US$12.86 on 19 November 2020. The American market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is down 7.0% over the same period.
분석 기사 • Feb 09Why We Like The Returns At Ocean Bio-Chem (NASDAQ:OBCI)Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
분석 기사 • Jan 27Is Weakness In Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?Ocean Bio-Chem (NASDAQ:OBCI) has had a rough three months with its share price down 14%. However, stock prices are...
분석 기사 • Jan 14Do Ocean Bio-Chem's (NASDAQ:OBCI) Earnings Warrant Your Attention?Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Is New 90 Day High Low • Jan 07New 90-day low: US$12.17The company is down 20% from its price of US$15.22 on 08 October 2020. The American market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Household Products industry, which is flat over the same period.
분석 기사 • Jan 01This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)We'd be surprised if Ocean Bio-Chem, Inc. ( NASDAQ:OBCI ) shareholders haven't noticed that the Executive VP of Sales...
Recent Insider Transactions • Dec 31Board Member recently sold US$120k worth of stockOn the 29th of December, Gregor Dornau sold around 9k shares on-market at roughly US$14.07 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of US$464k more than they bought in the last 12 months.
분석 기사 • Dec 28Shareholders of Ocean Bio-Chem (NASDAQ:OBCI) Must Be Delighted With Their 610% Total ReturnLong term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
분석 기사 • Dec 15Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been SellingIt is not uncommon to see companies perform well in the years after insiders buy shares. The flip side of that is that...
분석 기사 • Dec 03Is Ocean Bio-Chem (NASDAQ:OBCI) Using Too Much Debt?Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
분석 기사 • Nov 21A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO SalaryPeter Dornau has been the CEO of Ocean Bio-Chem, Inc. (NASDAQ:OBCI) since 1973, and this article will examine the...
Valuation Update With 7 Day Price Move • Nov 21Market pulls back on stock over the past weekAfter last week's 18% share price decline to US$12.43, the stock is trading at a trailing P/E ratio of 12.5x, down from the previous P/E ratio of 15.3x. This compares to an average P/E of 24x in the Household Products industry in the US. Total returns to shareholders over the past three years are 209%.
Reported Earnings • Nov 15Third quarter 2020 earnings released: EPS US$0.49The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: US$19.2m (up 53% from 3Q 2019). Net income: US$4.66m (up 314% from 3Q 2019). Profit margin: 24% (up from 9.0% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 35% per year but the company’s share price has increased by 53% per year, which means it is tracking significantly ahead of earnings growth.
Valuation Update With 7 Day Price Move • Nov 10Market pulls back on stock over the past weekAfter last week's 26% share price decline to US$12.50, the stock is trading at a trailing P/E ratio of 20.1x, down from the previous P/E ratio of 27.1x. This compares to an average P/E of 23x in the Household Products industry in the US. Total returns to shareholders over the past three years are 212%.
Valuation Update With 7 Day Price Move • Oct 21Market bids up stock over the past weekAfter last week's 17% share price gain to US$17.48, the stock is trading at a trailing P/E ratio of 28.2x, up from the previous P/E ratio of 24.1x. This compares to an average P/E of 26x in the Household Products industry in the US. Total returns to shareholders over the past three years are 280%.
Recent Insider Transactions • Sep 18COO, VP recently sold US$72k worth of stockOn the 16th of September, William Dudman sold around 5k shares on-market at roughly US$15.50 per share. In the last 3 months, there was an even bigger sale from another insider worth US$90k. William has been a seller over the last 12 months, reducing personal holdings by US$154k.